Ultraviolet (experimental/investigational*)

Blood irradiation therapy is a procedure in which the blood is exposed to low level red light (often laser light).  In the case of intranasal UV therapy, it is the rich blood supply coursing  through the nasal capillary beds.  The nasal cavity also contains many superficial nerve ending that may be affected.. 

Most research on blood irradiation therapy has been conducted in Germany, Russia and China,[1] while smaller-scale research has been performed in other countries such as Britain. Blood irradiation therapy can be administered through a catheter in a vein, through the blood vessels inside the nose or applied externally through the skin. If intranasal therapy works, it affords a much more convenient methods of UV-blood administration.

Normally exposure to UV kills off bacteria, but this depends on the intensity of the light. Hospitals can use UV to sterilize. Swimming pools and aquariums can pump water past UV light to clean the water and it is used for drinking water too. The difference with these systems is they rely on pumping all the water past the UV light – similar to Dr. Wald’s treatment method of choice. Namely, capillary blood flow.

Several websites quote a paper from Virgil Hancock from the 1940s who claimed the following benefits:

  • Inactivation of toxins
  • UV light exposure to cutaneous nerve endings may suppress the inflammatory response particularly for acute pain.
  • Destruction and inhibition of growth of bacteria.
  • Increase in the oxygen combining power of the blood and oxygen transportation to organs.
  • Activation of steroid hormones.
  • Vasodilatation thus having the potential to improve circulation
  • Activation of white blood cells.
  • Decreased platelet aggregation
  • Stimulation of fibrinolysis (the breakdown of blood clots)
  • Decreased viscosity of blood
  • Stimulation of corticosteroid production
  • Improved microcirculation
  • Broad band ultraviolet B radiation (UVB) has a well known anti-inflammatory effects. Moreover, it decreases neural damage and cutaneous nerve density.

The nasal cavity's easily accessible, rich vascular plexus permits topically administered drugs, medications and light to rapidly achieve effective blood levels while avoiding intravenous catheters and sometimes oral ingestion. Intranasal UV light therapy is painless and is an effective method of exposure of 

Because of this easily accessed vascular bed, nasal administration of medications is emerging as a promising method of delivering medications directly to the blood stream.  This method of delivery can eliminate the need for intravenous catheters while still achieving rapid, effective blood levels of the medication administered.

Administering medications via the nasal mucosal offers several advantages:

  1. The rich vascular plexus of the nasal cavity provides a direct route into the blood stream that easily cross mucous membranes of the nose.

  2. Painless

  3. Direct exposure of the rich nerve supply in the nasal cavity. For health professionals interested in a more complex explanation of how nerves endings in the nose may cause various pain syndromes in the head should read these links: https://www.ncbi.nlm.nih.gov/pubmed/10537009   https://www.ncbi.nlm.nih.gov/pubmed/105370090073.pdfhttp://www.brighamandwomens.org/Departments_and_Services/neurology/services/NeuroOphthamology/Images/SelectedPublications/TrigeminalNerve.pdf

 

According to Dr. Wald, “UV capillary or other methods of UV-blood exposure are not likely complete in and of themselves, but should be combined with other appropriate medical and/or health approaches.

Added12/7/2016: UC blood capillary exposure is not an approved treatment for any particular health problem or condition. 

References

1.     Moshkovska, T.; Mayberry, J. (2005). "It is time to test low level laser therapy in Great Britain". Postgraduate Medical Journal 81 (957): 436–441.doi:10.1136/pgmj.2004.027755PMC 1743298PMID 15998818.

2.     Meshalkin E N, Sergievskii V S, Primenenie pryamogo lazernogo izlucheniya v eksperimental'noi i klinicheskoi meditsine (Application of Direct Laser Radiation in Experimental and Clinical Medicine), (Novosibirsk: Nauka), 1981

3.     Weber, MH; Fussgänger-May TW (2007). "Intravenous laser blood irradiation". German Journal of Acupuncture and related Techniques 50 (3): 12–23. doi:10.1078/0415-6412-00282.

4.     Lee, G.; Ikeda, R. M.; Dwyer, R. M.; Hussein, H.; Dietrich, P.; Mason, D. T. (1982). "Feasibility of intravascular laser irradiation for in vivo visualization and therapy of cardiocirculatory diseases". American heart journal 103 (6): 1076–1077. doi:10.1016/0002-8703(82)90576-2PMID 7081024.

5.     Schwartz, SO; Kaplan SR; Stengle J; Stevenson FL (1952). "Ultraviolet Irradiation of Blood in Man"JAMA 149 (13): 1180–3. doi:10.1001/jama.1952.02930300006002.PMID 14938136.

6.     "Ultraviolet Blood Irradiation Intravenous Treatment". CA: A Cancer Journal for Clinicians20: 248. 1970. doi:10.3322/canjclin.20.4.248.

7.     Barrett, S (23 June 2010). "Index of Questionable Treatments"Quackwatch. Retrieved2010-07-23.

8.     Harrington, James; Li, Junheng (1998). Biomedical optics and lasers: diagnostics and treatment: 16–18 September 1998, Beijing, China. Bellingham, Washington: SPIE. ISBN 0-8194-3009-9.

 

DISCLAIMER: The information contained on this website and on this page are for educational purposes only and are meant meant to imply that UV intranssal therapy is a substitute for the standard of care for various medical conditions. 

*EXPERIMENTAL/INVESTIGATIONAL

 

Investigational" or "Experimental

"Investigational" or "experimental" refers to the use of a service, procedure or supply that is not recognized by your insurance company and/or the FDA (Food and Drug Administration) and/or the AMA (American Medical Association) or other appropriate boards and/or governing bodies or organizations (all of the aforementioned considered as “PLAN”), as standard medical care for the condition, disease, illness or injury being treated. A service, procedure or supply includes, but is not limited to the diagnostic service, treatment, facility, equipment, drug or device. A service is considered investigational (experimental) if any of the following criteria are met:

 

1. The services, procedures or supplies requiring Federal or other Governmental body approval, such as drugs and devices, do not have unrestricted market approval from the Food and Drug Administration (FDA) or final approval from any other governmental regulatory body for use in treatment of a specified condition. Any approval that is granted as an interim step in the regulatory process is not a substitute for final or unrestricted market approval.

 

2. There is insufficient or inconclusive medical and scientific evidence to permit the Plan to evaluate the therapeutic value of the service, procedure or supply. (Adequate evidence is defined as at least two documents of medical and scientific evidence that indicate that the proposed treatment is likely to be beneficial to the member.)

 

3. There is inconclusive medical and scientific evidence in peer-reviewed medical literature that the service, procedure or supply has a beneficial effect on health outcomes.

 

4. The service, procedure or supply under consideration is not as beneficial as any established alternatives and is not a replacement for the standard of medical care for your health condition(s).

 

5. There is insufficient information or inconclusive scientific evidence that, when used in a non-investigational setting, the service, procedure or supply has a beneficial effect on health outcomes or is as beneficial as any established alternatives. 

 

If any portion of this notice is deemed unenforceable the remainder will remain potentially enforceable and in effect.

Scientific links describing the many health problems that may benefit from UV-blood irradiation in general

https://scholar.google.com/scholar?q=uv+blood+irradiation+therapy&hl=en&as_sdt=0&as_vis=1&oi=scholart&sa=X&ved=0ahUKEwjxj5Lsg9XKAhUEHh4KHcsAAzYQgQMIGjAA